Skip to main content
Jeffrey Marks, MD, Urology, Merriam, KS

JeffreyMarksMD

Urology Merriam, KS

Male Sexual Dysfunction, Minimally Invasive Surgery, Stone Disease

Physician

Dr. Marks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Marks' full profile

Already have an account?

  • Office

    7450 Kessler St
    Merriam, KS 66204
    Phone+1 913-831-1003

Summary

  • Jeffrey Marks, MD, is a urologist based in Merriam, KS, with subspecialties in Male Sexual Dysfunction, Minimally Invasive Surgery, and Stone Disease. He completed his MD at the University of Missouri-Columbia School of Medicine in 2015, followed by a urology residency at the University of Colorado that ended in 2021. He also has a degree in Biology from the University of Missouri. Dr. Marks has experience in renal reconstruction, stone disease, erectile dysfunction, bladder cancer, and robotic surgery. He has made notable contributions to his field, publishing research articles on topics such as the role of depression, alcohol, and marijuana on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia treatment and the role of inflammation in Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms.

Education & Training

  • University of Colorado
    University of ColoradoResidency, Urology, 2015 - 2021
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2015, MD
  • University of Missouri
    University of MissouriB.S., Biology, Cum Laude, 2007 - 2011

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2021 - 2025
  • MO State Medical License
    MO State Medical License 2021 - 2025
  • American Board of Urology Urology

Publications & Presentations

PubMed

Reviews

Very likely to recommend   April 2024

Very understanding and sympathetic to the situation. I felt very well informed at the end of the appointment.